Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis

Abstract

Data on fertility after autologous hematopoietic stem cell transplantation (aHSCT) in women with multiple sclerosis (MS) are inconclusive. This study aims to report on post-aHSCT menstrual resumption in a multi-center MS-women cohort. Out of 43 women, 30 (70%) recovered menses after a mean time of 6.8 months. Older age (odds ratio (OR) = 0.5, p < 0.0001) and previous pulsed cyclophosphamide (OR = 0.44, p = 0.005) were independently associated with a reduced menstrual recovery probability. Conditioning regimens’ intensity resulted not associated with post-procedure amenorrhea. Our results highlight younger age as significantly associated with menses recovery; proper fertility counseling for MS women candidated to aHSCT both prior- and post-transplantation is therefore warranted.

Keywords

Aggressive multiple sclerosis amenorrhea autologous hematopoietic stem cell transplantation fertility menstrual cycle

Get full access to this article

View all access options for this article.

References

Mancardi

Sormani

Muraro

, et al. Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis. Mult Scler 2018; 24(3): 245–255.

Sharrack

Saccardi

Alexander

, et al. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: Updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transplant 2020; 55(2): 283–306.

Maciejewska

Snarski

Wiktor-Jędrzejczak

A preliminary online study on menstruation recovery in women after autologous hematopoietic stem cell transplant for autoimmune diseases. Exp Clin Transplant 2016; 14(6): 665–669.

Snarski

Snowden

Oliveira

, et al. Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: A retrospective study of the EBMT autoimmune diseases working party (ADWP). Bone Marrow Transplant 2015; 50(2): 216–220.

Amato

Portaccio

Fertility, pregnancy and childbirth in patients with multiple sclerosis: Impact of disease-modifying drugs. CNS Drugs 2015; 29(3): 207–220.

Cavalla

Rovei

Masera

, et al. Fertility in patients with multiple sclerosis: Current knowledge and future perspectives. Neurol Sci 2006; 27(4): 231–239.

Thöne

Kollar

Nousome

, et al. Serum anti-Mullerian hormone levels in reproductive-age women with relapsing remitting multiple sclerosis. Mult Scler 2015; 21(1): 41–47.

Sepúlveda

Ros

Martínez-Lapiscina

, et al. Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study. Mult Scler 2016; 22(4): 564–568.

Massarotti

Scaruffi

Matteo

, et al. Beyond fertility preservation: Role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients. Hum Reprod 2019; 34(8): 1462–1469.